Literature DB >> 34292486

The effect of VAV3 polymorphisms on thyroid cancer.

Wanli Ren1, Chongwen Xu1, Shiyang Wang1, Huajing Li1, Hao Dai1, Fangli Yang1, Yuan Shao2, Yanxia Bai3.   

Abstract

BACKGROUND: The incidence of thyroid cancer is rising rapidly in China, but there are few studies on the risk factors of thyroid cancer in the Chinese Han population.
METHODS: We performed this case-control study of 510 patients and 509 controls to for determine the linkage of VAV3 variants (rs17019602, rs7521681, rs4915076, and rs1777451) with thyroid cancer susceptibility by computing the odds ratio (OR) and 95% confidence intervals (CI). Multi-factor dimension reduction (MDR) analysis was conducted to assess interaction of VAV3 genetic variants.
RESULTS: We found that rs7521681 was remarkably related to a higher risk of thyroid cancer (OR = 1.74, p = 0.012), whereas rs4915076 (OR = 0.66, p = 0.001) significantly decreased thyroid cancer susceptibility. Stratified analyses showed that rs4915076 had a protective role in thyroid cancer in both ages >45 years (OR = 0.70, p = 0.017) and age ≤45 years (OR = 0.63, p = 0.007). Rs17019602 could increase the susceptibility of thyroid cancer in men (OR = 4.76, p = 0.049). Rs7521681 was related to an increased risk of thyroid cancer in women (OR = 1.97, p = 0.012). Rs4915076 could protect individuals from thyroid cancer both in men (OR = 0.60, p = 0.031) and women (OR = 0.68, p = 0.010). Moreover, rs4915076 was the best single-locus model to predict thyroid cancer. Interestingly, the interaction model of rs17019602, rs7521681, rs4915076, rs1777451, and age was a candidate gene-environment model.
CONCLUSION: Our results indicated VAV3 variants were associated with thyroid cancer, which provides a new sight into etiology of thyroid cancer.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Case–control study; Risk factors; Thyroid cancer; VAV3 polymorphisms

Mesh:

Substances:

Year:  2021        PMID: 34292486     DOI: 10.1007/s12020-021-02827-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  4 in total

1.  [Trend of incidence and mortality on thyroid cancer in China during 2003 - 2007].

Authors:  Yu-Qin Liu; Shu-Quan Zhang; Wan-Qing Chen; Li-Li Chen; Si-Wei Zhang; Xiao-Dong Zhang; Rong-Shou Zheng
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-10

Review 2.  Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis.

Authors:  Daniela Schmid; Gundula Behrens; Carmen Jochem; Marlen Keimling; Michael Leitzmann
Journal:  Eur J Epidemiol       Date:  2013-11-17       Impact factor: 8.082

3.  Novel associations for hypothyroidism include known autoimmune risk loci.

Authors:  Nicholas Eriksson; Joyce Y Tung; Amy K Kiefer; David A Hinds; Uta Francke; Joanna L Mountain; Chuong B Do
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

4.  Genetic model selection for a case-control study and a meta-analysis.

Authors:  Nobuyuki Horita; Takeshi Kaneko
Journal:  Meta Gene       Date:  2015-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.